Literature DB >> 11557177

Coffee, caffeine, and the risk of liver cirrhosis.

G Corrao1, A Zambon, V Bagnardi, A D'Amicis, A Klatsky.   

Abstract

PURPOSE: To evaluate the effect of the consumption of caffeine-containing beverages on the risk of symptomatic liver cirrhosis (LC).
METHODS: From 1994 to 1998, all the consecutive cirrhotic inpatients admitted in 19 collaborative hospitals for signs of liver decompensation in whom the diagnosis of liver cirrhosis was made for the first time (274 cases) and one or two gender, age, and place of residence pair matched individuals (458 controls) were recruited. Data on years of education, lifetime cigarette use, lifetime intake of alcohol- and caffeine-containing beverages, usual consumption of 180 food items, and on markers of hepatitis B and C viral infection were collected.
RESULTS: A statistically significant trend toward lowered cirrhosis risk with increasing exposure to coffee was observed. The LC odds ratios decreased from 1.0 (reference category: lifetime abstainers from coffee) to 0.47 (95% confidence interval: 0.20, 1.10), 0.23 (0.10, 0.53), 0.21 (0.06, 0.74), and 0.16 (0.05, 0.50) in 1, 2, 3, and 4 or more cups of coffee drinkers, respectively. There was no convincing evidence that coffee consumption modifies the effects of the known risk factors of liver cirrhosis (alcohol intake and viruses infection).
CONCLUSIONS: These findings support the hypothesis that coffee, but not other beverages containing caffeine, may inhibit the onset of alcoholic and nonalcoholic liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557177     DOI: 10.1016/s1047-2797(01)00223-x

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  34 in total

1.  Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease.

Authors:  James Philip Esteban; Amreen Dinani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-03

Review 2.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

Review 3.  Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

Authors:  William N Hannah; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2016-05       Impact factor: 3.199

4.  Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; Wan-Cheng Chow; Renwei Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Hepatology       Date:  2014-06-24       Impact factor: 17.425

5.  Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Michael Roerecke; Afshin Vafaei; Omer S M Hasan; Bethany R Chrystoja; Marcus Cruz; Roy Lee; Manuela G Neuman; Jürgen Rehm
Journal:  Am J Gastroenterol       Date:  2019-10       Impact factor: 10.864

6.  Coffee prevents CCl(4)-induced liver cirrhosis in the rat.

Authors:  Mario G Moreno; Enrique Chávez; Liseth R Aldaba-Muruato; José Segovia; Paula Vergara; Víctor Tsutsumi; Mineko Shibayama; Yadira Rivera-Espinoza; Pablo Muriel
Journal:  Hepatol Int       Date:  2011-01-25       Impact factor: 6.047

Review 7.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

Review 8.  Coffee Consumption and Prevention of Cirrhosis: In Support of the Caffeine Hypothesis.

Authors:  Jonathan A Dranoff
Journal:  Gene Expr       Date:  2017-09-11

Review 9.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

10.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.